1. Medtech Insight
  2. >>Policy & Regulation

CMS Proposes To Deny Most HCPCS Code Requests For DMEPOS Items

CMS met this week, and will again on June 3, to hear arguments in support of establishing new or revised level II HCPCS codes for 33 different durable medical equipment, prosthetics and orthotics items and medical supplies. But in preliminary rulings the agency signaled plans to deny all but two of the requests.

CMS is proposing to deny most requests for new or revised level II Healthcare Common Procedure Coding System reimbursement codes in 2015.

Of the 33 separate durable medical equipment, prosthetics and orthotics items, as well as medical supplies, that are the subject...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

Arima Genomics’ CEO Sets Sight On Replacing Standard Testing With 3D Genomics Lymphoma Assay

 
• By Marion Webb

Arima Genomics launched its new Aventa Lymphoma test aimed at helping pathologists detect lymphomas missed by standard FISH analysis. Initially positioned as complementary technology, Arima hopes to become the new standard test.

FDA Advisory Committee To Discuss Use Of UV Light Devices For Device Disinfection

 
• By Brian Bossetta

The US FDA’s General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee will meet in October to discuss an emerging technology for disinfection. Device-related pandemic preparedness is also on the agenda.

Brazil Asks Stakeholders To Weigh In On Ways To Improve Country’s Trial Environment

 
• By Francesca Bruce

Brazil is planning to update its National Clinical Research Action Plan to make the country a more competitive location to conduct R&D.

Global Medtech Guidance Tracker: August 2025

 
• By Sabah Javed Peerzade

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 60 documents have been posted on the tracker since its last update.

More from Medtech Insight

Execs On The Move: August 25–29, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 
• By Natasha Barrow

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

Ketryx Raises $39M To Accelerate Regulated AI Development Platform

 
• By Shubham Singh

Ketryx relies on a combination of continuous validation, testing, and human oversight to ensure the platform remains compliant and reliable as AI capabilities evolve, CEO Kaminski said.